Role of Glia in Memory Deficits Following Traumatic Brain Injury: Biomarkers of Glia Dysfunction

Historically, glial cells have been recognized as a structural component of the brain. However, it has become clear that glial cells are intimately involved in the complexities of neural networks and memory formations. Astrocytes, microglia, and oligodendrocytes have dynamic responsibilities which s...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in integrative neuroscience Vol. 10; p. 7
Main Authors Sajja, Venkata S S S, Hlavac, Nora, VandeVord, Pamela J
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Research Foundation 29.02.2016
Frontiers Media S.A
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Historically, glial cells have been recognized as a structural component of the brain. However, it has become clear that glial cells are intimately involved in the complexities of neural networks and memory formations. Astrocytes, microglia, and oligodendrocytes have dynamic responsibilities which substantially impact neuronal function and activities. Moreover, the importance of glia following brain injury has come to the forefront in discussions to improve axonal regeneration and functional recovery. The numerous activities of glia following injury can either promote recovery or underlie the pathobiology of memory deficits. This review outlines the pathological states of glial cells which evolve from their positive supporting roles to those which disrupt synaptic function and neuroplasticity following injury. Evidence suggests that glial cells interact extensively with neurons both chemically and physically, reinforcing their role as pivotal for higher brain functions such as learning and memory. Collectively, this mini review surveys investigations of how glial dysfunction following brain injury can alter mechanisms of synaptic plasticity and how this may be related to an increased risk for persistent memory deficits. We also include recent findings, that demonstrate new molecular avenues for clinical biomarker discovery.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ObjectType-Article-1
ObjectType-Feature-2
Reviewed by: Mikulas Chavko, Naval Medical Research Center, USA; Peethambaran Arun, Walter Reed Army Institute of Research, USA; Esther Shohami, Hebrew Universtiy of Jerusalem, Israel
Edited by: Ye Chen, Navy Medical Research Center, USA
ISSN:1662-5145
1662-5145
DOI:10.3389/fnint.2016.00007